3 Stocks I Saw on T...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.13 0.05 | 2.40%
06/04/12 - 04:00 PM ET
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorStem Cell Stocks
- Usermurphman Portfolio 1
- UserSUPRATRADE HOT STOCKS (BUY ...
Latest CYTX Headlines from TheStreet
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Cytori Therapeutics Inc. (CYTX): Today's Featured Drugs Loser 09.29.11 | 04:09 pm
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- Biotech Stock Mailbag: Cytori Therapeutics 05.20.11 | 07:05 am
- Cytori Therapeutics Inc. Stock Downgraded (CYTX) 05.10.11 | 06:05 am
- Cytori Stock Hits New 52-Week High (CYTX) 04.04.11 | 10:04 am
- Cytori Therapeutics Inc. Stock Upgraded (CYTX) 03.24.11 | 06:03 pm
Press Releases for CYTX
- Cytori Therapeutics Announces Independent Clinical Study Results In Breast Reconstruction Presented At The Association Of Breast Surgery Conference - Business Wire 05.17.11 | 05:05 am
- Catholic Healthcare West President/CEO Lloyd H. Dean To Join Cytori Therapeutics’ Board Of Directors - Business Wire 11.03.10 | 07:11 am
- Cytori Announces Exercise In Full Of Overallotment Option And Closing Of Public Offering Of Common Stock; Raises $19.3 Million In Net Proceeds - Business Wire 10.13.10 | 09:10 am
- Cytori Therapeutics Prices Public Offering Of Common Stock - Business Wire 10.08.10 | 08:10 am
- Cytori Therapeutics Proposes Common Stock Public Offering - Business Wire 10.07.10 | 04:10 pm
- Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function In Preclinical Acute Kidney Injury Study Data Published Today - Business Wire 10.05.10 | 08:10 am
- Cytori Extends Distribution Agreement With GE Healthcare; Key Focus On Research Market - Business Wire 09.16.10 | 07:09 am
- Cytori Therapeutics Announces Fall 2010 U.S. Conference Schedule - Business Wire 09.13.10 | 07:09 am
- Cytori Issued Celution® System Patent For Orthopedic & Spinal Disc Diseases - Business Wire 08.12.10 | 07:08 am
- Cytori’s PureGraft™ System Receives European Approval For Fat Grafting Procedures - Business Wire 07.29.10 | 08:07 am
Partner Headlines for CYTX
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
- UPDATE 1-Cytori, Astellas Pharma sign $10 mln equity deal - Reuters 12.07.10 | 07:12 am
